Clover May

Clover is an associate in the Emerging Companies and M&A team in London. She specialises in advising companies and investors in the technology and life science sectors on venture capital investments, M&A transactions and general corporate matters.

最新新闻和观点

View Clover's insights

点击此处了解更多

酒店与休闲

Advising on Tropic Biosciences' US$105 million Series C financing

2026年3月25日

作者

就业、养老金和流动性

New legislation governing Allocation of Tips to come into force in July 2024

2024年3月21日

Quick read

作者 Clover May

点击此处了解更多

员工激励

Lexology Executive Compensation & Employee Benefits 2023 - UK chapter

2023年11月14日

作者

点击此处了解更多

Clover May

专长

执业领域和服务团队

行业

最新新闻和观点

Advising on Tropic Biosciences' US$105 million Series C financing

Clover May

专长

执业领域和服务团队

行业

最新新闻和观点

Advising on Tropic Biosciences' US$105 million Series C financing

Related news & insights

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act

Proposed Amendments to the EU Medical Device Regulation

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

Impact of the new Biotech Act on Clinical Trials in the EU

Advising Eurofins on the sale of its electrical and electronic testing business for EUR575 million

Advising on Sona's US$45 million Series B funding

Life Sciences Legal Lens – Vol. 1

Taylor Wessing strengthens Corporate/M&A practice with Equity Partner Jan Hückel

Hungary opens health data infrastructure for AI development

相关人员

与我会面：